-
srdr.ahrq.gov/projects/1520/studies/186160
January 01, 2015 - )
Population: All Participants
Time Point
Measure
IR: Percutaneous drainage
4-6 … morbidities
Population: All Participants
Time Point
Measure
IR: Percutaneous drainage
4-6 … Morbidity
Population: All Participants
Time Point
Measure
IR: Percutaneous drainage
4-6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186693
January 01, 2019 - 56
Mean
92.6
92.2
SD
22.8
21.3
6 … 69.3
SD
21.7
13.6
N Analyzed
P-Value
Mean
SD
6 … P-Value
Mean
0.69
0.74
SD
0.21
0.20
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186762
January 01, 2014 - Active irritable bowel syndrome, GI bleeding, endometriosis or dysmenorrhea (6 months before baseline … ), or current or historical use of biologic drugs, immunomodulators, or systemic/rectal steroids (6 wks … Comments ( 0 ) |
Post/View
Other_2 (include definition in %)
6- … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/197240
January 01, 2020 - disruption/infection within 30 days after index colectomy; inflammatory bowel disease; chemotherapy within 6 … months prior to or after index colectomy; radiation therapy any time prior to or within 6 months after … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186781
January 01, 2019 - P-Value
1.00
6 years
N Analyzed
18
197
Adj. … P-Value
0.332
6 years
N Analyzed
97
135
Adj. … P-Value
0.693
6 years
N Analyzed
18
197
Adj. … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186839
January 01, 2019 - 6
Deleted Successfully
Deleted Successfully
Outcome: Treatment failure
… days
N Analyzed
18
18
P-Value
0.49
Counts
6 … days
N Analyzed
18
18
P-Value
0.73
Median
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186820
January 01, 2016 - Preoperative percutaneous abscess drainage
Comments ( 0 ) |
Post/View
6 … Post/View
KQ 4: Time Since Last Episode of Diverticulitis
Range
6- … Measure
Elective surgery
30 days
N Analyzed
1059
Counts
64
Percentage
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186750
January 01, 2014 - Active irritable bowel syndrome, GI bleeding, endometriosis or dysmenorrhea (6 months before baseline … ), or current or historical use of biologic drugs, immunomodulators, or systemic/rectal steroids (6 wks … 10: 2.7
Other_2 (include definition in %)
6-10: 1.4 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/extraction_forms/2069
September 04, 2020 - Specify
Question 5
Duration of intervention
Question 6
Duration data type
Absolute (all the same … Specify Not reported
Question 6
Funder
Industry (fully or in part) Non-industry (fully) Not reported … reported row and Definition' column Select a value for the Not reported row and %' column
Question 6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186816
January 01, 2002 - 0.005
Counts
42
19
Percentage
38.53
17.43
6 … 0.005
Counts
44
19
Percentage
40.36
17.43
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1542/extraction_forms/2094
Not reported
Question 6
Do you have any NOTES regarding the arms in this study? … No/not reported
Question 6
In what COUNTRY was the study done? … Question 6
What was the GESTATIONAL AGE DISTRIBUTION of the women in the study? … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186800
January 01, 2019 - diverticulitis (grades Ib, II, III, or IV); (4) sepsis; (5) systemic inflammatory response syndrome (SIRS); (6) … 64
61
P-Value
0.690
Counts
5
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186845
January 01, 2014 - Enter a numeric value or title (required) years
N Analyzed
299
Counts
Percentage
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186817
January 01, 2007 - 15
P-Value
between 0.05 and 0.1
Counts
3
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1542/studies/186860
January 01, 1998 - P-Value
>=0.05
Counts
11
6 … 90
P-Value
>=0.05
Counts
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186782
January 01, 2010 - <60
Time Point
Measure
Elective surgery
NR years
N Analyzed
358
Counts
6 … >69
Time Point
Measure
Elective surgery
NR years
N Analyzed
211
Counts
6 … <60
Time Point
Measure
Elective surgery
NR years
N Analyzed
358
Counts
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186807
January 01, 2013 - years
N Analyzed
45
47
P-Value
>0.05
Counts
6 … Point
Measure
Pharm: 5-ASA
Placebo
2 years
N Analyzed
45
47
Counts
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1520/studies/186802
value or title (required) years
N Analyzed
21
30
Counts
0
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1542/studies/186833
January 01, 2014 - Not reported N/A
N Analyzed
626
57
6 … Delivery N/A
N Analyzed
626
57
6 … Delivery N/A
N Analyzed
626
57
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the
-
srdr.ahrq.gov/projects/1542/studies/186834
January 01, 2011 - 5
Triptans: Sumatriptan
Comments ( 0 ) |
Post/View
6 … 22
362
157
6 … Counts
17
6 … Did the authors use an appropriate analysis method that controlled for all the important confounding domains … If Y/PY to 1.4: Were confounding domains that were controlled for measured validly and reliably by the